Destabilization of MYC/MYCN by the mitochondrial inhibitors, metaiodobenzylguanidine, metformin and phenformin.
第一作者:
Stephanie S,Wang
第一单位:
Department of Anatomy and Cell Biology, College of Medicine, University of Illinois at Chicago, Chicago, IL 60612, USA.
作者:
医学主题词
3-碘苄胍(3-Iodobenzylguanidine);乙酰化作用(Acetylation);抗肿瘤药(Antineoplastic Agents);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);细胞凋亡(Apoptosis);细胞周期(Cell Cycle);细胞系, 肿瘤(Cell Line, Tumor);细胞增殖(Cell Proliferation);基因表达调控, 肿瘤(Gene Expression Regulation, Neoplastic);基因, 肿瘤抑制(Genes, Tumor Suppressor);人类(Humans);二甲双胍(Metformin);线粒体(Mitochondria);神经母细胞瘤(Neuroblastoma);核蛋白质类(Nuclear Proteins);癌基因蛋白质类(Oncogene Proteins);苯乙双胍(Phenformin);原癌基因蛋白质c-myc(Proto-Oncogene Proteins c-myc);增量调节(Up-Regulation)
DOI
10.3892/ijmm.2013.1545
PMID
24190252
发布时间
2021-10-21
- 浏览30
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



